Effect of thrombin in the injury, especially on chemotaxis and accumulation of the inflammatory cells

凝血酶在损伤中的作用,特别是对炎症细胞趋化和积累的作用

基本信息

项目摘要

Thrombin is a member of serine protease family, and has been well known to have multifunctions in coagulation, inflammation, regulation of blood vessels and central nervous systems (CNS). While thrombin effects on the brain tissues in restoring from damage, it also causes the post brain damage through glial reaction and scar formation after injury.In order to elucidate the effects of thrombin on the purpose of therapeutic application, we investigated the following studies by using anti-thrombin drug, named argatroban, in a rat brain injury model, histologically :(1) Effect of thrombin on the inflammatory cells : infiltration and accumulation of inflammatory cells, especially around the small vessels through expressing the adhesion molecules on the endothelial cells, and(2) Effects of thrombin on cells comprising central nervous system : glial response, especially, of the astrocytes when excess of thrombin or inhibitor for thrombin were administered in a rat brain injury model.Result 1 … More : Thrombin inhibitor suppressed the infiltration of inflammatory cells and excessive gliosis mainly composed of vimentin-positive astroglia, but not effected on the expression of GFAP-positive astrocytes along the injured area of rat brain.Result 2 : Thrombin accelerated the infiltration of inflammatory cells and the expression of E-selectin and ICAM-1 on the endothelial cells along the edge of brain defect.Result 3 : Thrombin inhibitor suppressed the infiltration of inflammatory cells and the expression of ICAM-1 on the endothelial cells, and also suppressed the accumulation of Mac-1 positive cell along the edge of brain defect.ConclusionThrombin caused infiltration of inflammatory cells through the expression of adhesion molecules on the endothelial cells, and led to secondary brain damage after acute inflammation.Thrombin accelerated proliferation of vimentin-positive astrocytes after brain injury.Thrombin inhibitor may minimize the secondary brain damage, and promote the neural regeneration. Less
凝血酶是丝氨酸蛋白酶家族的一员,众所周知具有凝血、炎症、血管调节和中枢神经系统(CNS)等多种功能。凝血酶在影响脑组织损伤恢复的同时,也通过损伤后的胶质反应和疤痕形成引起脑损伤。为了阐明凝血酶在治疗应用中的作用,我们使用抗凝血酶药物阿加曲班在大鼠脑损伤模型中进行了以下组织学研究:(1)凝血酶对炎症细胞的影响:炎症细胞的浸润和积累, (2) 凝血酶对中枢神经系统细胞的影响:在大鼠脑损伤模型中给予过量凝血酶或凝血酶抑制剂时,尤其是星形胶质细胞的神经胶质反应。结果 1 …更多:凝血酶抑制剂抑制炎症细胞的浸润和过度的神经胶质细胞增生,主要由 波形蛋白阳性星形胶质细胞,但不影响大鼠脑损伤区GFAP阳性星形胶质细胞的表达。结果2:凝血酶加速炎性细胞的浸润以及脑缺损边缘内皮细胞上E-选择素和ICAM-1的表达。结果3:凝血酶抑制剂抑制炎性细胞的浸润和脑缺损边缘内皮细胞上ICAM-1的表达。 结论凝血酶通过内皮细胞上粘附分子的表达引起炎症细胞浸润,导致急性炎症后继发性脑损伤。凝血酶加速脑损伤后波形蛋白阳性星形胶质细胞的增殖。凝血酶抑制剂可以最大程度地减少继发性脑损伤, 并促进神经再生。较少的

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Suzuki Michiyasu: "Increased levels of nitrite/nitrate in the cerebrospinal fluid of patients with subarachnoid hemorrhage"Neurosurg Rev. No22. 96-98 (1999)
Suzuki Michiyasu:“蛛网膜下腔出血患者脑脊液中亚硝酸盐/硝酸盐水平升高”Neurosurg Rev. No22。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
鈴木倫保: "Argatrobanの脳血管攣縮予防効果"脳血管攣縮. 14. 350-353 (1999)
铃木道吉:“阿加曲班对脑血管痉挛的预防作用”《脑血管痉挛》14. 350-353 (1999)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
鈴木倫保: "重症クモ膜下出血の術後管理-ドレナージ・外減圧・バルビツレート-"脳循環代謝. 12(1). 1-5 (2000)
Michiyoshi Suzuki:“严重蛛网膜下腔出血的术后处理 - 引流、外部减压、巴比妥类药物 -”《脑循环与代谢》12(1) (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suzuki Michiyasu: "Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage"Neurosurgery. 44(3). 487-493 (1999)
铃木道保:“蛛网膜下腔出血后脑脊液中血液凝固和凝血酶的外在途径”神经外科。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suzuki Michiyasu: "Prophylactic effeect of argatroban for vasospasm following subarachnod hemorrhage"Vasospasm. No14. 350-353 (1999)
铃木道保:“阿加曲班对蛛网膜下腔出血后血管痉挛的预防作用”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUZUKI Michiyasu其他文献

SUZUKI Michiyasu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUZUKI Michiyasu', 18)}}的其他基金

Protective effects of Focal brain cooling on cortical spreading depolarization in rats
局部脑冷却对大鼠皮质扩散去极化的保护作用
  • 批准号:
    16K15646
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Evaluation and control of epilepsy dynamics based on multimodal brain signals and thermal neuromodulation using focal brain cooling
基于多模式脑信号和局灶性脑冷却热神经调节的癫痫动力学评估和控制
  • 批准号:
    15H05719
  • 财政年份:
    2015
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Experimental and theoretical investigations on effects of focal brain cooling on the generalized seizures
局灶性脑冷却对全身性癫痫发作影响的实验和理论研究
  • 批准号:
    25540136
  • 财政年份:
    2013
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of drug delivery system for central nervous system disease using with temperature control devise
使用温度控制装置的中枢神经系统疾病药物输送系统的开发
  • 批准号:
    22659261
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Application of focal brain cooling for intractable epilepsy
局灶性脑冷却在顽固性癫痫中的应用
  • 批准号:
    22390276
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation and control of cerebral neurophysiological function with focal brain-cooling for the purpose of clinical application.
以临床应用为目的,通过局灶性脑冷却来阐明和控制脑神经生理功能。
  • 批准号:
    19390380
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Neurotoxic effects of exogenous tissue-type plasminogen activator on the normal brain
外源性组织型纤溶酶原激活剂对正常脑的神经毒性作用
  • 批准号:
    14571313
  • 财政年份:
    2002
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

Thrombin/PAR1-MEK-ERK1/2通路介导的体外软骨组织构建及对体内软骨缺损修复的作用及机制
  • 批准号:
    81902306
  • 批准年份:
    2019
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
基于Thrombin/pH程序化响应释药的血小板膜仿生智能共递送载体及其抗缺血性脑卒中研究
  • 批准号:
    31671018
  • 批准年份:
    2016
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
衰老时自发性脑出血转归特点的机制研究
  • 批准号:
    30400459
  • 批准年份:
    2004
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Postoperative reduction in thrombin generation in cardiac surgery: pathogenesis and evaluation
心脏手术术后凝血酶生成减少:发病机制和评估
  • 批准号:
    23H03001
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
  • 批准号:
    10759950
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Engineering Receptors to Control Platelet Activation and Therapeutic Release
工程受体来控制血小板激活和治疗释放
  • 批准号:
    10607886
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
  • 批准号:
    10605739
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Lymphatic Dysfunction in the Pathogenesis of COPD
慢性阻塞性肺病发病机制中的淋巴功能障碍
  • 批准号:
    10590330
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Novel Broad-Spectrum Point-of-Care Coagulometer
新型广谱护理点凝血计
  • 批准号:
    10707617
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
  • 批准号:
    10678074
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Synthetic circuits for therapeutic platelet production and immunomodulation
用于治疗性血小板生成和免疫调节的合成回路
  • 批准号:
    10745237
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
MAM Proteins in Lung Vascular Injury
MAM 蛋白在肺血管损伤中的作用
  • 批准号:
    10680808
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了